FDAnews
www.fdanews.com/articles/196924-quotients-covid-19-diagnostic-gets-ce-mark
CE mark

Quotient’s COVID-19 Diagnostic Gets CE Mark

May 4, 2020

Quotient said it received a CE mark in record time for its MosaiQ COVID-19 antibody test.

The Swiss-based company said the blood test has 99.8 percent accuracy in detecting IgG and IgM antibodies combatting the SARS-CoV-2 coronavirus.

Quotient said the test can detect the antibodies at a very early stage. The  test is now available in Europe.

View today's stories